PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jrsocmedLink to Publisher's site
 
J R Soc Med. 1987 July; 80(7): 406–409.
PMCID: PMC1290898

New drugs for mental diseases? New diseases for old drugs?

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (875K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Talbott JA. Presidential address: Our patients' future in a changing world: the imperative for psychiatric involvement in public policy. Am J Psychiatry. 1985 Sep;142(9):1003–1014. [PubMed]
  • Parker G, O'Donnell M, Walter S. Changes in the diagnoses of the functional psychoses associated with the introduction of lithium. Br J Psychiatry. 1985 Apr;146:377–382. [PubMed]
  • Walton J. The science of clinical neurology. J R Soc Med. 1986 Jan;79(1):5–14. [PMC free article] [PubMed]
  • Carroll BJ, Feinberg M, Greden JF, Tarika J, Albala AA, Haskett RF, James NM, Kronfol Z, Lohr N, Steiner M, et al. A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility. Arch Gen Psychiatry. 1981 Jan;38(1):15–22. [PubMed]
  • Arana GW, Baldessarini RJ, Ornsteen M. The dexamethasone suppression test for diagnosis and prognosis in psychiatry. Commentary and review. Arch Gen Psychiatry. 1985 Dec;42(12):1193–1204. [PubMed]
  • LABORIT H, HUGUENARD P, ALLUAUME R. Un nouveau stabilisateur végétatif; le 4560 RP. Presse Med. 1952 Feb 13;60(10):206–208. [PubMed]
  • Bowden CL. Current treatment of depression. Hosp Community Psychiatry. 1985 Nov;36(11):1192–1200. [PubMed]
  • Dupont WD. Randomized vs. historical clinical trials. Are the benefits worth the cost? Am J Epidemiol. 1985 Dec;122(6):940–946. [PubMed]
  • Coccaro EF, Siever LJ. Second generation antidepressants: a comparative review. J Clin Pharmacol. 1985 May-Jun;25(4):241–260. [PubMed]
  • Møller SE, Reisby N, Elley J, Krautwald O, Ortmann J, Larsen OB. Biochemical and diagnostic classification and serum drug levels: relation to antidepressive effect of imipramine. Neuropsychobiology. 1985;13(4):160–166. [PubMed]
  • Møller SE. Tryptophan to competing amino acids ratio in depressive disorder: relation to efficacy of antidepressive treatments. Acta Psychiatr Scand Suppl. 1985;325:3–31. [PubMed]
  • Pichot P. Nosological developments in European psychiatry and psychopharmacology. Pharmacopsychiatry. 1986 Jan;19(1):23–25. [PubMed]
  • Kielholz P, Terzani S, Gastpar M. Treatment for therapy resistant depressions. Int Pharmacopsychiatry. 1979;14(2):94–100. [PubMed]
  • Pöldinger W. Die biologisch-pharmakologisch orientierten Behandlungsmethoden der Depressionen unter besonderer Berücksichtigung der Anliegen der Praxis. Wien Klin Wochenschr. 1985 Feb 15;97(4):165–175. [PubMed]
  • Bech P, Kastrup M, Rafaelsen OJ. Mini-compendium of rating scales for states of anxiety depression mania schizophrenia with corresponding DSM-III syndromes. Acta Psychiatr Scand Suppl. 1986;326:1–37. [PubMed]
  • Cleghorn JM. Formulation: a pedagogic antidote to DSM-III. Compr Psychiatry. 1985 Nov-Dec;26(6):504–512. [PubMed]
  • Williams JB. The multiaxial system of DSM-III: where did it come from and where should it go? I. Its origins and critiques. Arch Gen Psychiatry. 1985 Feb;42(2):175–180. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press